Structures by: Martins F. T.
Total: 126
2(C13H10ClN5O5),H2O
2(C13H10ClN5O5),H2O
RSC Advances (2020) 10, 21 12384-12394
a=11.666(5)Å b=8.002(5)Å c=33.179(5)Å
α=90° β=99.513(5)° γ=90°
C50H66F4GdN5O15S
C50H66F4GdN5O15S
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.2563(7)Å b=14.5337(8)Å c=16.3077(9)Å
α=74.841(2)° β=89.676(2)° γ=61.641(2)°
C50H66F4N5O15STb
C50H66F4N5O15STb
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.259(2)Å b=14.542(2)Å c=16.277(3)Å
α=74.901(7)° β=89.893(7)° γ=61.587(7)°
C50H62Cl4EuN5O16S
C50H62Cl4EuN5O16S
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.0412(6)Å b=26.3866(11)Å c=16.2993(6)Å
α=90° β=90.570(3)° γ=90°
C50H68Cl4GdN5O16S
C50H68Cl4GdN5O16S
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.1427(6)Å b=26.4518(10)Å c=16.2848(6)Å
α=90° β=90.531(3)° γ=90°
C50H68Cl4DyN5O16S
C50H68Cl4DyN5O16S
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.0648(4)Å b=26.3669(8)Å c=16.2078(4)Å
α=90° β=90.377(3)° γ=90°
C50H68Cl4N5O16STb
C50H68Cl4N5O16STb
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.0302(2)Å b=26.3753(4)Å c=16.2526(2)Å
α=90° β=90.3740(10)° γ=90°
C34H26DyF4N4O13S,2(H2O),C16H36N
C34H26DyF4N4O13S,2(H2O),C16H36N
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.2143(5)Å b=14.5314(6)Å c=16.1788(5)Å
α=74.941(3)° β=89.817(3)° γ=61.784(4)°
C23H19ClN2O3
C23H19ClN2O3
New Journal of Chemistry (2019) 43, 3 1313
a=6.2427(2)Å b=13.2218(4)Å c=24.3513(8)Å
α=90° β=93.176(2)° γ=90°
C24H22N2O4
C24H22N2O4
New Journal of Chemistry (2019) 43, 3 1313
a=16.4477(4)Å b=7.3740(2)Å c=16.5927(4)Å
α=90° β=97.642(2)° γ=90°
C23H19N3O5
C23H19N3O5
New Journal of Chemistry (2019) 43, 3 1313
a=5.7534(7)Å b=18.2637(17)Å c=18.7499(19)Å
α=90° β=98.750(8)° γ=90°
C30H24N6,2(C2H3O2),6.5(H2O)
C30H24N6,2(C2H3O2),6.5(H2O)
New J. Chem. (2017)
a=23.6688(15)Å b=13.4856(9)Å c=24.0246(15)Å
α=90° β=105.012(3)° γ=90°
C14H16CdN2O5,2(H2O)
C14H16CdN2O5,2(H2O)
New J. Chem. (2017)
a=11.4204(12)Å b=21.689(3)Å c=15.3958(17)Å
α=90° β=97.293(3)° γ=90°
C24H22CdN4O4,0.5(C10H8N2),3(H2O)
C24H22CdN4O4,0.5(C10H8N2),3(H2O)
New J. Chem. (2017)
a=8.9084(10)Å b=12.5072(15)Å c=14.9281(18)Å
α=105.185(8)° β=99.615(8)° γ=102.311(8)°
C14H14HgN2O4,H2O
C14H14HgN2O4,H2O
New J. Chem. (2017)
a=10.255(2)Å b=12.619(2)Å c=13.064(2)Å
α=90° β=108.023(4)° γ=90°
2(C22H19N4O2Zn),2(C2H3O2),H2O
2(C22H19N4O2Zn),2(C2H3O2),H2O
New J. Chem. (2017)
a=9.316(13)Å b=13.037(18)Å c=13.162(16)Å
α=61.74(3)° β=81.33(4)° γ=85.11(4)°
C22H19HgN4O2,0.5(C10H8N2),C2H3O2,8(H2O)
C22H19HgN4O2,0.5(C10H8N2),C2H3O2,8(H2O)
New J. Chem. (2017)
a=12.380(2)Å b=19.659(3)Å c=15.164(2)Å
α=90° β=108.148(9)° γ=90°
C32H34N4O12Zn3
C32H34N4O12Zn3
New J. Chem. (2017)
a=8.0907(3)Å b=9.8783(5)Å c=12.7432(6)Å
α=106.076(2)° β=98.523(2)° γ=108.795(2)°
C20H12CoN10O4,ClO4,C2H6OS,H2O
C20H12CoN10O4,ClO4,C2H6OS,H2O
New J. Chem. (2017)
a=10.1227(2)Å b=22.0252(6)Å c=12.4721(3)Å
α=90° β=94.1980(10)° γ=90°
C92H61Co6N48O20S10
C92H61Co6N48O20S10
New J. Chem. (2017)
a=19.5807(5)Å b=24.4918(6)Å c=14.4619(4)Å
α=90° β=117.8860(10)° γ=90°
Lamivudine perchlorate monohydrate
C8H12N3O3S,ClO4,H2O
CrystEngComm (2018) 20, 22 3049
a=6.2322(7)Å b=13.2055(15)Å c=17.424(2)Å
α=90° β=90° γ=90°
Lamivudine hydrogen sulfate
C8H12N3O3S,HO4S
CrystEngComm (2018) 20, 22 3049
a=6.756(2)Å b=10.726(3)Å c=23.809(8)Å
α=90° β=90° γ=90°
Lamivudine sulfate
2(C8H12N3O3S),O4S
CrystEngComm (2018) 20, 22 3049
a=6.7148(14)Å b=17.982(6)Å c=19.374(5)Å
α=90° β=90° γ=90°
Lamivudine duplex VI
2(C8H12N3O3S),2(C8H11N3O3S),2(C2Cl3O2),H2O
CrystEngComm (2018) 20, 22 3049
a=14.8380(10)Å b=14.8380(10)Å c=42.003(3)Å
α=90° β=90° γ=120°
Lamivudine duplex V
2(C8H12N3O3S),2(C8H11N3O3S),2(C2F3O2),H2O
CrystEngComm (2018) 20, 22 3049
a=29.3603(5)Å b=29.3603(5)Å c=20.4187(4)Å
α=90° β=90° γ=120°
2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide
C14H11ClN2O4S
CrystEngComm (2013) 15, 19 3767
a=8.1051(3)Å b=7.1178(3)Å c=12.2732(5)Å
α=90° β=103.646(4)° γ=90°
Ticlopidine hydrochloride form II
C14H15Cl2NS
CrystEngComm (2011) 13, 19 5737
a=5.4410(2)Å b=12.2260(4)Å c=21.7050(7)Å
α=90° β=101.040(2)° γ=90°
Chlortalidone Form IV
4(C14H11ClN2O4S),CHCl3
CrystEngComm (2012) 14, 19 6173
a=7.763(2)Å b=12.938(5)Å c=17.221(7)Å
α=72.48(2)° β=87.107(16)° γ=86.201(17)°
Doxycycline monohydrate
C22H24N2O8,H2O
CrystEngComm (2012) 14, 7 2532
a=5.9241(1)Å b=9.4808(2)Å c=18.5568(4)Å
α=90.00° β=91.192(2)° γ=90.00°
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl) - (1H)-pyrimidin-2-one hydrochloride
C8H12N3O3S,Cl
CrystEngComm (2012) 14, 7 2373
a=5.7060(2)Å b=11.9670(5)Å c=8.3401(4)Å
α=90.00° β=104.273(2)° γ=90.00°
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl) - (1H)-pyrimidin-2-one hydrochloride
C8H12N3O3S,Cl
CrystEngComm (2012) 14, 7 2373
a=5.6520(3)Å b=11.9240(6)Å c=8.3220(6)Å
α=90.00° β=104.760(3)° γ=90.00°
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1, 3-oxathiolan-5-yl)- (1H)-pyrimidin-2-one hydrochloride monohydrate
C8H12N3O3S,H2O,Cl
CrystEngComm (2012) 14, 7 2373
a=5.2554(1)Å b=17.1944(6)Å c=6.8210(2)Å
α=90.0000° β=98.774(2)° γ=90.0000°
C18H19NO4
C18H19NO4
CrystEngComm (2016) 18, 12 2144
a=12.713(16)Å b=8.649(11)Å c=15.231(19)Å
α=90° β=103.798(15)° γ=90°
C15H11NO4
C15H11NO4
CrystEngComm (2016) 18, 12 2144
a=11.620(3)Å b=13.232(3)Å c=13.981(3)Å
α=105.7760(10)° β=90.626(2)° γ=112.7210(10)°
C50H66EuF4N5O15S
C50H66EuF4N5O15S
Dalton transactions (Cambridge, England : 2003) (2020) 49, 45 16106-16124
a=14.2518(10)Å b=14.5549(9)Å c=16.2386(8)Å
α=74.932(5)° β=89.752(5)° γ=61.685(7)°
C14H16N2O5Zn,2(H2O)
C14H16N2O5Zn,2(H2O)
New J. Chem. (2017)
a=20.1431(8)Å b=8.0764(4)Å c=21.7544(9)Å
α=90° β=97.401(2)° γ=90°
C20H12N10NiO4,H2O
C20H12N10NiO4,H2O
New J. Chem. (2017)
a=8.8015(15)Å b=10.0257(17)Å c=13.876(2)Å
α=74.233(3)° β=83.559(3)° γ=64.292(3)°
4-amino-1-((2R,5S)-2-(hydroxymethyl)-1, 3-oxathiolan-5-yl)- (1H)-pyrimidin-2-one hydrochloride monohydrate
C8H12N3O3S,H2O,Cl
CrystEngComm (2012) 14, 7 2373
a=5.2927(2)Å b=17.2524(12)Å c=6.8518(4)Å
α=90.00° β=98.865(3)° γ=90.00°
C44H64N4O6
C44H64N4O6
CrystEngComm (2017) 19, 13 1792
a=10.0009(5)Å b=10.7218(5)Å c=21.5824(11)Å
α=81.629(3)° β=81.306(3)° γ=73.137(3)°
C88H90O17
C88H90O17
CrystEngComm (2017) 19, 13 1792
a=18.5360(13)Å b=33.680(3)Å c=16.0933(11)Å
α=90° β=113.747(4)° γ=90°
C32H36O6S2
C32H36O6S2
CrystEngComm (2017) 19, 13 1792
a=17.286(3)Å b=18.154(3)Å c=18.412(3)Å
α=114.488(9)° β=93.801(9)° γ=116.859(9)°
C46H70N4O7S
C46H70N4O7S
CrystEngComm (2017) 19, 13 1792
a=47.845(9)Å b=10.2532(12)Å c=19.755(4)Å
α=90° β=102.025(11)° γ=90°
C73H67Na3O26
C73H67Na3O26
CrystEngComm (2016) 18, 37 6987
a=14.174(4)Å b=18.194(5)Å c=26.052(6)Å
α=90° β=90° γ=90°
C288H246Na12O97
C288H246Na12O97
CrystEngComm (2016) 18, 37 6987
a=14.840(2)Å b=17.911(3)Å c=31.010(5)Å
α=79.663(11)° β=86.268(11)° γ=82.469(12)°
C76H72Na4O26S2
C76H72Na4O26S2
CrystEngComm (2016) 18, 37 6987
a=21.041(4)Å b=21.041(4)Å c=16.456(3)Å
α=90.00° β=90.00° γ=90.00°
C12H16Cl2N2O2
C12H16Cl2N2O2
CrystEngComm (2017) 19, 2 346
a=4.75320(10)Å b=8.1538(2)Å c=10.0237(2)Å
α=113.9970(10)° β=91.2750(10)° γ=90.0030(10)°
C6H6F3N3O2
C6H6F3N3O2
CrystEngComm (2017)
a=8.778(8)Å b=10.165(9)Å c=10.918(9)Å
α=78.86(2)° β=69.57(3)° γ=72.29(4)°
C12H19N2O12P3
C12H19N2O12P3
CrystEngComm (2017)
a=21.4140(16)Å b=9.4256(9)Å c=9.4548(7)Å
α=90° β=99.380(5)° γ=90°
C6H6Cl3N3O2
C6H6Cl3N3O2
CrystEngComm (2017)
a=13.6957(3)Å b=5.53110(10)Å c=14.3450(3)Å
α=90° β=109.2240(10)° γ=90°
C12H16N2O8P2
C12H16N2O8P2
CrystEngComm (2017)
a=9.2640(7)Å b=4.7949(3)Å c=17.7033(13)Å
α=90° β=90.536(2)° γ=90°
C4H6BrN3
C4H6BrN3
CrystEngComm (2017)
a=5.0554(9)Å b=7.5644(13)Å c=9.0290(14)Å
α=72.096(11)° β=79.191(11)° γ=80.625(11)°
C12H12Br2N2
C12H12Br2N2
CrystEngComm (2017)
a=5.1052(8)Å b=10.2491(15)Å c=12.6953(18)Å
α=90° β=93.053(2)° γ=90°
C4H6ClN3
C4H6ClN3
CrystEngComm (2017)
a=4.9992(4)Å b=7.3893(7)Å c=8.8313(8)Å
α=72.451(6)° β=78.656(5)° γ=79.410(6)°
C7H13N3O4S
C7H13N3O4S
CrystEngComm (2017)
a=9.0017(7)Å b=21.128(2)Å c=11.7627(9)Å
α=90° β=90.617(5)° γ=90°
C25H29.6Ca2Cu3N9O24.3
C25H29.6Ca2Cu3N9O24.3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 33 11539-11553
a=25.7295(18)Å b=20.4448(18)Å c=20.9078(15)Å
α=90° β=107.050(5)° γ=90°
C38H69Cu4N12O56.5Sr4.5
C38H69Cu4N12O56.5Sr4.5
Dalton transactions (Cambridge, England : 2003) (2018) 47, 33 11539-11553
a=6.26030(10)Å b=13.1593(3)Å c=24.1169(6)Å
α=79.244(2)° β=87.2880(10)° γ=77.0270(10)°
C100H118Cu12N36O97Sr8
C100H118Cu12N36O97Sr8
Dalton transactions (Cambridge, England : 2003) (2018) 47, 33 11539-11553
a=26.2280(15)Å b=20.5339(13)Å c=21.4349(13)Å
α=90° β=106.657(4)° γ=90°
Zalcitabine hydrochloride
C9H14N3O3,Cl
CrystEngComm (2014) 16, 30 7013
a=5.5482(2)Å b=12.0260(5)Å c=8.5725(3)Å
α=90.00° β=104.6393(24)° γ=90.00°
Zalcitabine hydrochloride
C9H14N3O3,Cl
CrystEngComm (2014) 16, 30 7013
a=5.4672(20)Å b=11.9780(29)Å c=8.5397(20)Å
α=90.00° β=105.3269(18)° γ=90.00°
Lamivudine zalcitabine hydrochloride
C9H14N3O3,C8H12N3O3S,2(Cl)
CrystEngComm (2014) 16, 30 7013
a=6.692(1)Å b=8.886(1)Å c=10.412(1)Å
α=105.22(1)° β=99.04(1)° γ=107.50(1)°
Compound X
C60H60Cl1N5O4P2Ru1S1
CrystEngComm (2014) 16, 30 7013
a=9.800(5)Å b=16.008(5)Å c=34.268(5)Å
α=90° β=90° γ=90°
Ctd_cwbpy
C55H56Cl1N5O9P2Ru1
CrystEngComm (2014) 16, 30 7013
a=10.432(1)Å b=20.600(3)Å c=27.012(5)Å
α=90° β=98.20(5)° γ=90°
S-mandelic acid cocrystal of lamivudine R-mandelate trihydrate
C8H12N3O3S,C8H7O3,C8H8O3,3(H2O)
RSC Adv. (2015)
a=57.018(4)Å b=5.1662(4)Å c=9.3289(6)Å
α=90° β=95.689(4)° γ=90°
Lamivudine R-mandelate
C8H12N3O3S,C8H7O3
RSC Adv. (2015)
a=5.3230(12)Å b=17.152(2)Å c=19.884(2)Å
α=90° β=90° γ=90°
Lamivudine hydrogen hemihydrate phthalate
2(C8H12N3O3S),2(C8H5O4),H2O
CrystEngComm (2013) 15, 32 6311
a=5.3110(5)Å b=21.103(2)Å c=33.059Å
α=90° β=94.675(6)° γ=90°
Lamivudine 4,5-dichloro hydrogen phthalate
C8H12N3O3S,C8H3Cl2O4
CrystEngComm (2013) 15, 32 6311
a=8.9680(3)Å b=10.3880(4)Å c=11.4140(4)Å
α=99.427(3)° β=112.791(2)° γ=90.988(3)°
Lamivudine_Hydrobromide
C8H12N3O3S,Br
CrystEngComm (2015) 17, 28 5187
a=5.61900(10)Å b=12.2320(4)Å c=8.3840(3)Å
α=90° β=104.3040(12)° γ=90°
Lamivudine hydrochloride
C8H12N3O3S,Cl
CrystEngComm (2015) 17, 28 5187
a=6.0770(7)Å b=16.324(2)Å c=6.3440(7)Å
α=90° β=115.577(8)° γ=90°
Lamivudine_Hydrofluoride
C8H12N3O3S,F2H
CrystEngComm (2015) 17, 28 5187
a=5.43490(10)Å b=12.0714(3)Å c=8.6515(3)Å
α=90° β=103.854(2)° γ=90°
Lamivudine hydrogen phthalate
C8H12N3O3S,C8H5O4
CrystEngComm (2012) 14, 14 4562
a=5.39900(10)Å b=15.7550(4)Å c=20.6980(5)Å
α=90° β=90° γ=90°
Lamivudine salicylate monohydrate
C8H12N3O3S,C7H5O3,H2O
CrystEngComm (2012) 14, 14 4562
a=12.7246(12)Å b=5.2978(3)Å c=13.1688(9)Å
α=90° β=106.129(8)° γ=90°
Zalcitabine hydrochloride
C9H14N3O3,Cl
CrystEngComm (2014) 16, 30 7013
a=5.5482(2)Å b=12.0260(5)Å c=8.5725(3)Å
α=90.00° β=104.6393(24)° γ=90.00°
Lamivudine zalcitabine hydrochloride
C9H14N3O3,C8H12N3O3S,2(Cl)
CrystEngComm (2014) 16, 30 7013
a=6.692(1)Å b=8.886(1)Å c=10.412(1)Å
α=105.22(1)° β=99.04(1)° γ=107.50(1)°
Compound X
C60H60Cl1N5O4P2Ru1S1
CrystEngComm (2014) 16, 30 7013
a=9.800(5)Å b=16.008(5)Å c=34.268(5)Å
α=90° β=90° γ=90°
Ctd_cwbpy
C55H56Cl1N5O9P2Ru1
CrystEngComm (2014) 16, 30 7013
a=10.432(1)Å b=20.600(3)Å c=27.012(5)Å
α=90° β=98.20(5)° γ=90°
(4<i>R</i>,4a<i>S</i>,7a<i>R</i>,12b<i>S</i>)-3-Cyclopropylmethyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-<i>e</i>]isoquinolin-7-one ethyl acetate 0.33-solvate
3(C20H23NO4),C4H8O2
Acta Crystallographica Section C (2018) 74, 3
a=13.0034(4)Å b=14.0829(4)Å c=31.4790(10)Å
α=90° β=90° γ=90°
(4<i>R</i>,4a<i>S</i>,7a<i>R</i>,12b<i>S</i>)-3-Cyclopropylmethyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-<i>e</i>]isoquinolin-7-one diethyl ether hemisolvate
2(C20H23NO4),C4H10O
Acta Crystallographica Section C (2018) 74, 3
a=12.5992(2)Å b=13.1093(3)Å c=26.6586(6)Å
α=90° β=90° γ=90°
3β,20-Epoxy-3α,16-dihydroxy-15-oxo-7-pimaren-19,6β-olide
C20H26O6
Acta Crystallographica Section C Structural Chemistry (2018) 74, 8
a=6.6712(3)Å b=11.9999(5)Å c=22.2073(8)Å
α=90° β=90° γ=90°
3β,6β,16-Trihydroxy-7-pimaren-19,20β-olide monohydrate
C20H30O6,H2O
Acta Crystallographica Section C Structural Chemistry (2018) 74, 8
a=11.7555(14)Å b=20.224(2)Å c=8.0385(11)Å
α=90° β=90° γ=90°
(1<i>E</i>,4<i>E</i>)-1,5-Bis(4-fluorophenyl)penta-1,4-dien-3-one
C17H12F2O
Acta Crystallographica Section C (2019) 75, 6
a=30.184(3)Å b=5.8907(5)Å c=7.7144(6)Å
α=90° β=98.040(5)° γ=90°
2-(Thiophen-2-yl)-1,3-benzothiazole
C11H7NS2
Acta Crystallographica Section C (2019) 75, 6
a=13.0549(6)Å b=15.6867(8)Å c=20.0965(10)Å
α=90° β=100.315(2)° γ=90°
2-(Thiophen-2-yl)-1,3-benzothiazole
C11H7NS2
Acta Crystallographica Section C (2019) 75, 6
a=12.5339(3)Å b=13.5178(4)Å c=14.4107(4)Å
α=117.741(2)° β=92.687(2)° γ=106.548(2)°
2-(Thiophen-2-yl)-1,3-benzothiazole
C11H7N1S2
Acta Crystallographica Section C (2019) 75, 6
a=13.1146(6)Å b=14.8676(7)Å c=22.4297(10)Å
α=87.244(2)° β=80.719(2)° γ=68.535(2)°
Trisodium bis(carboxymethoxy)bis(carboxylatomethoxy)calix[4]arene tris(carboxymethoxy)(carboxylatomethoxy)calix[4]arene--2-(thiophen-2-yl)-1,3-benzothiazole--dimethyl sulfoxide--water (1/1/2/2)
3(Na),C36H30O122,C36H31O12,C11H7N1S2,2(C2H6OS),2H2O1
Acta Crystallographica Section C (2019) 75, 6
a=15.4853(5)Å b=32.7646(9)Å c=16.8635(4)Å
α=90° β=101.633(2)° γ=90°
Ethyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
C18H23NO4
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 780-783
a=8.4533(2)Å b=10.2380(3)Å c=10.2552(2)Å
α=90° β=107.8810(10)° γ=90°
2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
C6H9N2OS2,HO4S,H2O
Acta Crystallographica Section C (2008) 64, 7 o395-o397
a=5.8508(2)Å b=13.0999(4)Å c=15.4187(5)Å
α=90° β=90° γ=90°
<i>N</i>-{4-[(<i>E</i>)-3-(4-Ethoxyphenyl)prop-2-enoyl]phenyl}benzenesulfonamide
C23H21NO4S
Acta Crystallographica Section C (2013) 69, 3 267-272
a=8.4506(2)Å b=20.1587(6)Å c=14.2120(3)Å
α=90° β=119.098(2)° γ=90°
<i>N</i>-{4-[(<i>E</i>)-3-(4-Methoxyphenyl)prop-2-enoyl]phenyl}benzenesulfonamide
C22H19NO4S
Acta Crystallographica Section C (2013) 69, 3 267-272
a=11.8650(3)Å b=12.2420(3)Å c=14.7287(3)Å
α=68.0750(10)° β=81.6650(10)° γ=80.4370(10)°
<i>N</i>-(4-acetylphenyl)-2,5-dichlorobenzenesulfonamide
C14H11Cl2N1O3S1
Acta Crystallographica Section C (2011) 67, 7 o226-o229
a=13.3622(2)Å b=8.1542(2)Å c=15.6845(3)Å
α=90° β=120.1840(10)° γ=90°
<i>N</i>-(4-acetylphenyl)benzenesulfonamide
C14H13N1O3S1
Acta Crystallographica Section C (2011) 67, 7 o226-o229
a=13.0007(5)Å b=8.3615(4)Å c=12.5179(6)Å
α=90° β=98.118(3)° γ=90°
3,4-dihydroxybenzophenone monohydrate
C13H10O3,H2O
Acta Crystallographica Section C (2010) 66, 9 o463-o465
a=4.29200(10)Å b=23.2084(7)Å c=11.4552(3)Å
α=90° β=95.393(2)° γ=90°
2,2',4,4'-tetrahydroxybenzophenone dihydrate
C13H10O5,2(H2O)
Acta Crystallographica Section C (2012) 68, 4 o156-o159
a=15.1394(4)Å b=7.7629(3)Å c=11.0690(4)Å
α=90° β=100.628(2)° γ=90°
<i>cis</i>-Bis(1,10-phenanthroline-κ^2^<i>N</i>,<i>N</i>)bis(pyridin-4-amine- κ<i>N</i>^1^)ruthenium(II) bis(hexafluoridophosphate)
C34H28N8Ru2,2(F6P)
Acta Crystallographica Section E (2013) 69, 2 m75-m76
a=13.0943(3)Å b=14.5730(3)Å c=19.9366(5)Å
α=90° β=90° γ=90°
<i>cis</i>-Bis(2,2-bipyridine-κ^2^<i>N</i>,<i>N</i>')bis(pyridin-4-amine- κ<i>N</i>^1^)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
C30H28N8Ru2,2(F6P),C2H3N
Acta Crystallographica Section E (2013) 69, 2 m77-m78
a=10.8290(3)Å b=11.8890(3)Å c=16.1020(4)Å
α=104.0730(10)° β=99.114(2)° γ=107.761(2)°
Lamivudine Duplex III
6(C8H11N3O3S),4(C8H12N3O3S),4(C4H3O4),5.65(H2O)
Crystal Growth & Design (2014) 14, 9 4691
a=14.8814(15)Å b=25.3457(24)Å c=33.9620(28)Å
α=90.00° β=90.00° γ=90.00°
Doxycycline nitrate salt hemihydrate
2(C22H25N2O8)1,2(N1O3)1,1(O1H2)
Crystal Growth & Design (2014) 14, 8 3711
a=8.0679(2)Å b=8.9156(3)Å c=16.6791(5)Å
α=77.872(2)° β=87.581(2)° γ=74.133(3)°
Doxycycline acetic acid dihydrate
C22H24N2O8,2(O1H2),1(C2O2H4)
Crystal Growth & Design (2014) 14, 8 3711
a=6.4753(2)Å b=9.0970(4)Å c=42.8077(16)Å
α=90° β=90° γ=90°
C14H15N3O3
C14H15N3O3
The Journal of organic chemistry (2018) 83, 7 3516-3528
a=5.3340(14)Å b=28.191(8)Å c=13.242(4)Å
α=90° β=90.465(4)° γ=90°
C14H15N3O4
C14H15N3O4
The Journal of organic chemistry (2018) 83, 7 3516-3528
a=6.2149(17)Å b=5.5203(15)Å c=19.393(5)Å
α=90° β=93.525(4)° γ=90°